Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00336687
Other study ID # CHU63-0013
Secondary ID
Status Completed
Phase N/A
First received June 13, 2006
Last updated March 26, 2010
Start date July 2005
Est. completion date November 2006

Study information

Verified date March 2010
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.


Description:

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.


Recruitment information / eligibility

Status Completed
Enrollment 322
Est. completion date November 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Thrombopenia in reanimation

Exclusion Criteria:

- Pregnancy

- Contraindication of myelogram

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France Clermont-Ferrand University Hospital Clermont-Ferrand Auvergne

Sponsors (4)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Centre Hospitalier Universitaire de Saint Etienne, LA ROCHE SUR YON HOSPITAL, Moulins Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Epidemiology of Thrombopenia and its consequences. in reanimation Yes
Secondary The impact of cost and mortality of Thrombopenia in reanimation. in reanimation Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT05040776 - COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients Phase 2
Recruiting NCT02906878 - Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter N/A
Not yet recruiting NCT06455553 - Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. N/A
Completed NCT01013181 - Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults N/A
Not yet recruiting NCT03823079 - Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia Phase 2
Completed NCT04070599 - Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. Phase 3